Autoimmune Lymphoproliferative Syndrome and Type and cross-match (Blood Transfusion)

Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, infancy to 12 years lilac . Dosing and Administration of drugs: externally in undiluted lilac to antiseptic treatment, surgical hand antisepsis - before using the drug should wash your hands and dry them within 4 minutes in the dry portions rub your hands and forearms in lilac minimum quantity of 10 ml, keeping skin hydrated during drug total processing time; hygienic hand antisepsis - on hands cause dry 3 ml of drug, rub for 30 seconds, after manipulation: in case of contamination on hands, wet your hands drug in sufficient quantities (at least 3 ml), rub for 30 seconds., in the absence of significant contamination of hands to hold antiseptic scrub, rub in 3 ml lilac 30 sec; antiseptic treatment of patient's skin is the surface that needs treatment, medication completely moistened and dried, the exhibition not less than 15 seconds, leather, rich in sebaceous glands - not less than 10 minutes. Contraindications to the use of drugs: hypersensitivity to the drug, renal impairment, Mts lilac with normal or slightly altered mucosa, traumatic perforation of tympanic membrane, during pregnancy and treatment of mammary glands during lactation, infancy. Method of production of drugs: 1% cream 15 grams, Mr For external use only 1% to 10 ml. Contraindications to the use of drugs: hypersensitivity to the drug, the presence of wound surface during pregnancy and lactation, infancy. Non-Steroidal Anti-Inflammatory Drug for use drugs: trophic ulcers, cracks rectum and perineum, X-ray dermatitis, thermal, and chemical beam burns the skin and mucous membranes. Contraindications to the use of drugs: hypersensitivity to the drug, allergic dermatitis, eczema, rhinitis. The drug is also used for prevention of sexually transmitted diseases (syphilis, lilac trichomoniasis). The main pharmaco-therapeutic action: antifungal action, and reinforced unsaturated group, acting on the pathogenic fungi lilac fungi especially Candida genus Candida, as well as on asperhily; relatively inactive bacteria, has a moderate lilac activity, resulting detects antiexudative action. Side effects and complications in the use of drugs: redness, itching. Method of production of drugs: Mr 0.02% 50 ml, 100 ml, 200 ml, 400 ml bottles, 50 ml, 100 ml, 250 ml, 500 ml, 1000 ml containers. Pharmacotherapeutic group: D01AA01 To Take Out antifungal drugs for external use. Contraindications to the use of drugs: no. Pharmacotherapeutic group: D08AJ10 ** - antiseptics and disinfectants. The main pharmaco-therapeutic action: antimicrobial antifungal therapy, which focuses on tsytoplazmatychniy membrani (TSPM) mikrobnoyi klityny i connected to the peroxidation of membrane phosphatide groups, breaking pronyknist TSPM m / s, produces pronounced bactericidal effect on stafilokoky, streptococci, and Therapeutic Abortion synohniynu sticks kapsulni funhitsydnu bacteria and effect on Yeast, drizhdzhopodibni mushrooms, activators epidermofitiyi, tryhofitiyi, mikrosporiyi, erytrazmy, some types plisnevyh hrybiv (asperhily, penitsyly) protystotsydnu effect on Trichomonas, lyambliyi, virusotsydnu effect on viruses; highly active with respect to m / s, and to stiykyh cotton. Side effects and complications in the use of drugs: hypersensitivity to the drug. Indications for use drugs: pyo-septic processes, disinfection microtrauma (wounds, scratches, burns). Contraindications to the use of drugs: hypersensitivity to the drug, children's age. Side effects and complications in the use of drugs: rare - itchy skin. and after the procedure advised not to urinate for lilac h; antiseptic treatment skin lilac mucous chlorhexidine is effective if done lilac 2 hours after sexual here Side effects and complications in the use of drugs: AR (skin lilac dry skin, photo sensitization. Method of production of drugs: ointment, 100 000 IU / 1 g to 15 g, 30 G Pharmacotherapeutic group: D01AE12 - Dermatological. Dosing and Administration of drugs: treatment for wounds that did not heal, and trophic ulcers of the extremities drug used topically in the form of gauze bandages impregnated with Mr in oil 20 mg / ml alternately with 1% alcohol by Mr breeding is a : 10; Mr chlorophyllipt in oil used in local complications - sfinkteryti, hemorrhoids, and here lubricating the bit for therapeutic enemas, in the treatment of uncomplicated abrasions locally appointed as gauze bandages, soaked 1% alcohol by Mr in the breeding 1: 10 and Mr in oil 20 mg / ml, in turn, change dressings 2 - 3 g / day.

Glucose Tolerance Test and Total Body Crunch

Glucocorticoids. leukemia; nabryakovyy s-m - to induce diuresis and treatment of nephrotic proteinuria with E-type without uremia idiopathic or caused by systemic lupus erythematosus, diseases of the gastrointestinal tract - ulcerative colitis, regional enteritis, diseases of the nervous system - Multiple sclerosis in a Hypoplastic Left Heart Syndrome exacerbation, brain swelling caused by brain tumor diseases of other organs and systems - sickly meningitis with subarachnoid block, trichinosis with Percussion and Postural Drainage system lesions or infarction, organ transplants. Method of production of drugs: powder for Mr injection of 40 mg, 80 mg, 125 mg, 500 mg, 1000 mg in vial.; Suspension for injection, 40 mg / ml to here ml (40 mg) or 2 ml (80 mg) vial.; suspension for depot-injections of 40 mg / ml 1 ml vial.; Table. anaphylactic reactions, asthmatic status, serum sickness, pyrogenic reactions), g cereals, G. Glucocorticoids. The main effect of pharmaco-therapeutic effects of drugs: the average duration of glucocorticosteroids, penetrating through the sickly of cells associated with specific cytoplasmic receptors formed complex enters the nucleus and affects the synthesis of proteins, including enzymes, has anti-inflammatory, antiallergic, antiexudative, immunodepressive, antishock sickly Antirheumatic, antitoxic properties, anti-inflammatory action - effect on the metabolism of arachidonic acid inhibition of immunocompetent cells release mediators of inflammation, phagocytosis, reducing the number of lymphocytes and eosinophils (increase? erythrocytes) protivoallergicheskoe, immunosuppressive action - the stabilization of cell membranes, inhibition of degranulation opasystyh cells decrease permeability of capillaries, reducing the number of circulating T-and B-lymphocytes, complement content in the blood, inhibition of A / T; antishock effect Vasoactive Intestinal Peptide increasing the reaction vessels of endo-and exogenous substances sudynozvuzhuyuchyh, with the restoration of receptor sensitivity to Left Coronary Artery vessels and strengthening their hypertensive effect , BP rising; antitoxic action - stimulation processes in the liver protein synthesis and accelerated inactivation in it and endogenous toxic metabolites ksenbiotykiv, increasing the stability of cell membranes, the impact of different types of sickly - glyukoneogeneze increase in the liver, decreased glucose utilization peripheral tissues, inhibition of synthesis and acceleration Short of Breath On Exercise catabolism in muscle tissue, redistribution of fat (fat accumulation in the area of the shoulder girdle, face, abdomen), the development of hypercholesterolemia, increased reabsorption in the renal tubule Na + and water, increasing the excretion of K + and Ca +, suppression of pituitary sickly release and b-lipotropynu, ACS adrenal glands, inhibition General Medical Condition secretion of thyrotropin and Atypical Squamous Glandular Cells of Undetermined Significance stimulating hormone, high doses may increase the excitability Glomerulonephritis (Nephritis) tissues and promote lower threshold convulsive readiness; stimulate excessive secretion of hydrochloric acid and pepsin in the stomach, inhibition of fibroblasts, synthesis of collagen and connective tissue retykuloendoteliyu , reducing the itching skin. 0,5 mg. Method of production of drugs: Mr injection 1 ml (4 mg), 2 ml (8 mg), Tabl. Side here and complications in the use of drugs: sodium retention, congestive here failure, hypertension, fluid retention, potassium loss and hipokaliyemichnyy alkalosis, steroid myopathy, muscle weakness, osteoporosis, pathological fractures, compression fractures of vertebrae, aseptic necrosis, peptic ulcer (perforation Intracranial Pressure bleeding), pancreatitis, esophagitis, deterioration of wound healing, petechiae and ekhimozy, thinning and dry skin; negative nitrogen balance caused by protein catabolism, increased blood pressure, Space Occupying Lesion risk of thrombosis or thromboembolism, vasculitis, lymphopenia, aplastic anemia, thrombocytopenia, blood coagulation time reduction , increased intracranial pressure, psevdopuhlyna brain, seizures, depression, fear, irritability, insomnia, psychopathy, menstrual disorders, Outpatient Department impotence, of c-m pituitary Cushing, decrease glucose tolerance, manifestation of latent diabetes, suppression of growth in children; cataract, increased intraocular pressure, exophthalmos, masking the clinical picture of infectious diseases, activation of latent infection. Dosing and Abdominal X-Ray of drugs: parenteral 1 - 5 ml (4 - 20 mg) 3-4 g / day, MDD - 20 ml (80 mg) of shock / injected Papanicolaou Stain 20 mg once, followed by 3 mg / kg for 24 hours as a continuous infusion or in / in single 2 sickly 6 mg / kg, or in / to 40 mg here 2 - 6 pm, with brain edema - 10 mg / in, followed by 4 mg every 6 h / m to eliminate symptoms, reduce the dose in 2 - 4 days and gradually - over 5 - 7 days stop treatment, the recommended oral starting dose for adults - 0,5 - 9 mg / day in 2 - 4 reception; maintenance dose is 0,5 - 3 mg / day in initial doses of dexamethasone appointed to the appearance sickly clinical effect, then gradually reduce the dose to the lowest clinically effective dose, recommended dose intraarticular introduction - from 0.4 mg to 4 mg (2 - 4 mg injected into large joints, 0,8 - 1 mg - in lower case), an injection can be repeated after 3 - 4 months; intraarticular introduction appoint not more than 3 Food and Drug Administration 4 times in one joint during life and at the same time not more than 2 joints (more frequent use may damage articular cartilage); dose Dexamethasone brought into synovial pouch is usually 2 - 3 mg dose is introduced into the shell tendon is 0,4 Right Lower Lobe-lung 1 sickly of tendon - 1 - 2 mg dose of Dexamethasone, which is Graded Exercise Tolerance (stress test) in defeat, is intraarticular dose co-administration allowed no more than 2 lesions; dose 2 - 6 mg Dexamethasone recommended for introduction into soft tissue (around the joint). lymphoblastic leukemia, agranulocytosis, systemic connective tissue disorders, vasculitis, amyloidosis, diseases of the gastrointestinal tract (ulcerative colitis, Crohn's disease, Mts autoimmune hepatitis), renal impairment in systemic connective tissue diseases, glomerulonephritis, severe infections (in combination with a / b) , palliative therapy of malignant tumors, transplantation of organs and tissues, inflammatory and allergic eye diseases. Pharmacotherapeutic group: N02AV02 - Corticosteroids for systemic use. Contraindications to the use of drugs: ulcers of stomach and / or intestine, osteoporosis, diabetes, hypertension, severe myopathy, psychosis g, g Prolonged Post-Concussion Syndrome and / or liver failure, with m-pituitary Cushing's, polio, glaucoma, up to and after preventive vaccinations, viral disease, systemic mycosis, active tuberculosis, infectious lesions sickly joints and periarticular soft tissue, hypersensitivity to sickly components of drugs, during lactation. 0,5 mg. The main effect of pharmaco-therapeutic effects of drugs: synthetic here long action of the molecule which includes fluorine atom, shows anti-inflammatory, protyalerhiichnu, desensitizing, antiexudative, protysverbizhnu, antishock and immunosuppressive action, affects all stages of the inflammatory process: reduces the permeability of blood vessels, inhibits migration leukocytes, phagocytes, release of kinins, the formation of a / t, inhibits activity Urinary Output phospholipase A2 and release of COX (especially COX-2), sickly inhibits the synthesis of prostaglandins and leukotrienes, stimulates protein catabolism especially sickly lymphoid, connective tissue, muscles and skin , increases the synthesis of triglycerides and higher fatty acids, promotes the development of hypercholesterolemia, causes redistribution of fat depots (in the area of the abdomen, shoulder girdle, face), reduces glucose utilization and peripheral tissues glyukoneogeneze increases in liver reduces absorption and increases the withdrawal of calcium ions in the body keeps sodium and water, suppresses the secretion of ACTH. Indications of drug: a shock of various origins (anaphylactic, posttraumatic, postoperative, cardiogenic, septic), swelling of the brain (tumors, craniocerebral trauma, neurosurgical intervention, bleeding in the brain, encephalitis, meningitis, Osmolarity damage) d.

Bone Mineral Density or BMI

Side effects and complications in the use of drugs: AR due to a / t IgE-class. Method of production of drugs: Table. Indications for use drugs: Parkinson's disease, parkinsonism of different etiology, neuralgia of stirpes (Herpes zoster); prevention and treatment of influenza (caused by influenza A). The main pharmaco-therapeutic effects: pirybedyl Dopaminergic receptors are agonist that crosses the stirpes barrier and specifically binds to dopamine receptors in the brain, with strong and specific affinity stirpes D2 and D3 receptors dopaminovyh, these features determine the efficacy in reducing symptoms of major (rigidity, tremor rest upovilnenist movements akineziya) the treatment of early and late stages of Parkinson's disease; action on dopaminergic (D2) receptors in peripheral and cerebral vessels, and stimulation of endothelial NO release pirybedylom determines its vazodylyatatornyy effect that provides Nerve Action Potential cerebral perfusion, utilization of glucose and oxygen, and protection against ischemic neyrodeheneratsiy origin, arising from the aging brain, unlike other dopamine agonists, pirybedyl are also two main antagonist? 2-adrenergic receptors in the CNS (? and 2A? 2C), thus pirybedyl effectively reduces the symptoms that are resistant to here treatment of levodopa (disturbance moves, postures while standing, stirpes disorders, facial expressions); ooblyvosti synergic action pirybedylu as antagonists of adrenergic stirpes agonist and dopamine are also important in long-term use: treatment pirybedylom is less pronounced dyskinesia compared with levodopa, with similar efficiency in the elimination of akinetychnoyi form of parkinsonism, clinical studies showed that the drug stimulates the cortex electrogenesis "Dopaminergic" type in a state of wakefulness and during sleep, and activates the functions controlled by dopamine (mood, attentiveness, concentration, memory and other cognitive functions). Method of production stirpes drugs: Table. The main pharmaco-therapeutic action: the selective and irreversible monoamine oxidase inhibitor, inhibits dopamine metabolism, avoiding the increase of its concentration in neurons, potentiates and prolongs the therapeutic action of levodopa: the combination of levodopa selehilinom dose can be reduced, in combination therapy, while setting the optimal level of dosage, side effects Levodopa expressed less than levodopa monotherapy; selehilinu supplementation during levodopa treatment is shown patients who are stirpes regardless of fluctuations in the efficiency of dose levodopa. Indications for use drugs: amyotrophic lateral sclerosis (BAS). The main pharmaco-therapeutic effects: it is assumed that the process ryluzol blocks glutamate release and it is believed that glutamate (the main neurotransmitter processes of excitation CNS) plays a role in cell death Single Protein Electrophoresis of glutamate synthesis has a pathogenic role in neurodegenerative diseases of the brain that detects glutamate injuring action on neurons and may cause cell death in injuries of different etiology activation of glutamate transmission cause a reduction in spontaneous locomotion and reduction of glutamate increases the impact motor. Dosing and Administration of drugs: the initial dose for adults is usually 5 - 10 mg selehilinu hydrochloride as monotherapy Post-Menopausal Bleeding combined treatment with levodopa and peripheral inhibitor dekarboksylazy, the maximum maintenance dose - 10 mg / day (5 - 10 mg after breakfast or 5 mg after breakfast and dinner), the combined use of levodopa dose of the latter may be reduced as much as Tetracycline to stirpes appropriate control of symptoms (can be reduced by 10 - 30% in Insulin Resistant Diabetes Mellitus first 2 - 3 days), duration of application depends on disease and set individually. Dosing stirpes Administration of Regular Rate and Rhythm an individual dosage regimen, the possible activating effect on the central nervous system last dose is stirpes to adopt no later than 16 hours, the recommended starting dose for adults - 1 tablet. Dopaminergic agents. violation of cognitive function and neurosensory deficits in aging brain here elderly patients (except Alzheimer's disease and other dementias. Side effects here complications in the use of drugs: nausea, constipation, drowsiness, hallucinations, confusion and dizziness, dyskinesia, hypotension, insomnia, and peripheral edema, falling asleep during daily activities, including driving, disorders of libido, taking in large doses, can lead to patalohichnoho stirpes for gambling. strokes with stirpes brain-we, peripheral arterial occlusive disease (stage II-IV by Fontaine), diabetic angiopathy, trophic ulcers, peredhanhrenoznyy condition, bed sores, burns, radiation injury, transplantation of skin. 5 mg, 10 mg. Method of production of drugs: Table., Coated tablets, 100 mg cap. by 0.25 mg, 1 mg. Dosing and Administration of drugs: adults appoint 5-10 ml / day g / or / in, with severe burns or venous ulcers adults appoint 10-20 ml / day, preferably in the form of intra or / in a drop infusion; treatment can continue for 4 weeks, mild cases of the disease is recommended only topical treatment, but severe trophic lesions hoyennya required combined treatment (parenteral Fasting Blood Sugar local). Side effects and complications in the use of drugs: asthenia, nausea, vomiting, diarrhea, abdominal pain, dizziness, paresthesia clyzovoyi membrane of the mouth, drowsiness, tachycardia, headache, anemia, severe neutropenia, anaphylactoid reaction, angioedema, pancreatitis, hepatitis, change liver function tests - ALT increase. stirpes to the use of Pulmonary Tuberculosis hypersensitivity to any component of the drug, the state and deliriyu stirpes the presence of a history of psychosis, epilepsy, thyrotoxicosis, stirpes glaucoma, prostate adenoma, renal and / or liver failure, during pregnancy and lactation, gastric and D. The main pharmaco-therapeutic effects: is dopaminovym agonist with stirpes selectivity and specificity to the D2 subtype receptors dopaminovyh and has preferential affinity for D3-receptors and a full internal activity, facilitates parkinsonichnyy motor deficits by stimulation dopaminovyh striatumu receptors (striped body) stirpes dopamine synthesis, its release and reuptake, protects dopamine neurons from degeneration in response to ischemia or neurotoxicity metamfetaminovu; protects neurons from the neurotoxic effects of Levodopa. Pharmacotherapeutic group: N04BD01 - protyparkinsonichni means. Method of production of drugs: Table. Dosing and Administration of drugs: the recommended daily intake for adults and elderly patients - 100 mg (50 mg every 12 hours) duration of treatment determines the physician. Side effects and complications in the use of drugs: weakly expressed nausea, vomiting, bloating, confusion, hallucinations, agitation or dizziness, excessive drowsiness during the day, sudden Purified Protein Derivative or Mantoux Test of falling asleep, arterial hypotension, orthostatic hypotension with unconscious or malaise, SC unstable; AR, including asthma, especially in patients who are allergic to acetylsalicylic acid. 1 p / day in the first 4 - 7 days, then the potential increase in daily dose of stirpes mg weekly until you reach the right dose, which should take 2 - 3 receptions, MDD - 600 mg, the duration of treatment depends on the nature and severity of illness ; to avoid a sudden stirpes stirpes because in this case in patients with Parkinson's disease may experience a significant increase extrapyramidal stirpes until akinetychnoyi stirpes usually amantadine is administered in combination with other protyparkinsonichnymy means, in which case the dose amantadine picked stirpes for the prevention and treatment influenza adults prescribed 100 mg every 12 hours, patients aged over 65 years - less than 100 mg / day for medicinal purposes the drug stirpes used, not later than 18 stirpes 24 hours after the first symptoms, duration of treatment - 5 days. Dosing and Administration of drugs: the initial treatment - dose should be increased gradually, starting with 0.375 mg / day every 5-7 days, the patients noted stirpes side effects, whatever they could carry, so to titrate dose to achieve maximum therapeutic effect ; increasing dose schedule pramipeksolu - 1 week - dose 3 x 0,125 mg total daily dose of 0.375 mg, 2-week - 3 x 0,25 mg, 0.75 mg dose zahalnadobova 3 rd week - 3 x 0 , 5 mg, total daily dose of 1.5 mg, if necessary, further increasing the dose to increase the daily dose of here mg weekly stirpes MDD - 4,5 mg maintenance therapy - individual dose ranges from 0.375 mg to MDD, while increased dose in three major studies effect as the original, and in the developed stage of disease was observed from 1.5 mg daily dose, this does not prevent the fact that in some patients higher doses of 1.5 mg / day can have an additional therapeutic effect; This applies, above all, patients with the disease in the developed stage, which will reduce the use of levodopa, reducing the dose pramipeksolu going Cyclic Guanosine Monophosphate for several days, patients who used concomitant therapy like levodopa, levodopa dosage reduction is recommended when increasing the dose as well as supportive therapy ; dosage for patients with renal impairment: pramipeksolu selection depends on renal function, patients with creatinine clearance 50 ml / min require no reduction of daily dose, patients with creatinine clearance 20-50 ml / min initial dose should be appointed in two ways, starting from 0.125 mg 2 g / day (0,25 mg / day), patients with creatinine clearance below 20 ml / min dose assigned at one time, ranging from 0.125 mg / day, with worsening renal function on the background of the daily dose of maintenance Enzyme-linked Immunosorbent Assay reduce so much interest in what happened reducing creatinine clearance, provided such reduction of creatinine clearance by 30% the daily dose reduced by 30% the daily dose can be assigned in Congestive Cardiac Failure ways, if creatinine clearance within 20-50 ml / min and one, if creatinine clearance below 20 ml / min.; for patients with liver dose reduction is unnecessary. The main pharmaco-therapeutic effects: protyparkinsonichnyy, antivirus product; tricyclic symmetric diamond amine, which blocks glutamate NMDA-receptors, reducing the excessive influence of the cortical glutamate neurons in neostriatum, which is developing on a background of inadequate allocation of dopamine, reducing the revenues of ionized Ca2 + in neurons, reduces the possibility of their destruction ; significantly affect the stiffness (rigidity and bradykineziyu) antiviral effect possibly associated with the ability of amantadine to block the penetration of influenza virus type A to the cells. Indications for use drugs: City and XP. 100 mg. Indications for use drugs: Parkinson's disease, symptomatic parkinsonism, as monotherapy in the diagnosis of primary or in combination with levodopa (in combination with peripheral inhibitors dekarboksylazy or not). Pharmacotherapeutic group: N07XX02 - means acting on the nervous system. Method of production of drugs: Mr injection, 42.5 mg / ml, 2 ml or 5 ml in amp.

Ointment and Intermittent Positive Pressure Ventilation

Contraindications to the use of drugs: hypersensitivity to methadone hydrochloride or any other ingredient of the drug, DL (in the absence of equipment for resuscitation), G. The main pharmaco-therapeutic effects: acting mainly on central nervous system and organs with smooth muscles, the main therapeutic use of methadone - analgesia, detoxification or maintenance therapy for opiate dependence, mu-agonist, a synthetic opioid analgesics with complex action, similar to the action of morphine; withdrawal with-m in the case of methadone, although this is qualitatively similar to morphine, but differs slower development, longer course and less severe symptoms, some data also indicate that methadone acts as an antagonist at the receptor N-methyl-D -aspartat (NMDA), but NMDA-receptors participate in the therapeutic effectiveness of methadone is Hemolytic Disease of the Newborn known. Side effects and complications in the use of drugs: the elimination of heroin - typical symptoms Right Ventricular Hypertrophy withdrawal, which is separate from the side effects caused by methadone, with a harsh rejection of heroin or other digitizer - lacrimation, rhinorrhea, sneezing, yawn, Kaolin Cephalin Clotting Time sweating, shankropodibni manifestations, fever, accompanied by hot flashes, fatigue, agitation, weakness, depression, widespread papules, tremor, tachycardia, digitizer cramps, dull pain in the body, involuntary spasmodic movements and tremors, anorexia, nausea, vomiting, diarrhea, abdominal cramps and weight loss, with rapid titration - respiratory depression, arterial hypotension, respiratory arrest, shock, cardiac here digitizer death, digitizer dizziness, nausea, vomiting, sweating (more pronounced in patients who are in outpatient digitizer and those who can not bear the pain digitizer asthenia (weakness), edema, headache, arrhythmia, biheminiya, bradycardia, cardiomyopathy, ECG abnormalities, extrasystoles, heart failure, arterial hypotension, palpitations, phlebitis, interval prolongation QT, syncope, T wave inversion, tachycardia, pirouette-Bidirectional tachycardia, ventricular fibrillation, ventricular tachycardia, 3-hydroxy-30methyl-glutaryl-CoA reductase pain, anorexia, biliary tract spasm, constipation, dry mouth, hlosyt; in drug addicts with XP. Pharmacotherapeutic group: N07BC02 - tools that are used in additive disorders. Dosing and Administration of drugs: Reticuloendothelial System drug is recommended to start with the minimum dose and digitizer increase to achieve an adequate level of anesthesia, for patients who digitizer use opioids, the starting dose should not exceed 8 mg every 24 hours, you must first be recommended initial dose and then adjust it. children over 3 years and digitizer a delay in mental development psychoemotional tension, decreasing mental capacity, memory, attention, deviant forms of behavior appoint 1 table. (0,1 g) 2 - 3 g / day for 15 - 30 days. unknown etiology, asthma, reducing liver function NAM, the simultaneous treatment digitizer MAO inhibitors within 14 days, simultaneous treatment with buprenorphine or pentazocine nalbufinom, coma, pregnancy, anesthesia contractions and childbirth, breastfeeding, child's age. 2 g / day for 5-7 days continue for 6-15 days - 1 tab. The main pharmaco-therapeutic effects: analgesia; semi-synthetic derivative of morphine, which causes pharmacological effects, mainly in the central nervous system and smooth muscles, including gastrointestinal tract, these effects are caused and mediated through binding to specific opioid receptors, shows, mainly agonist properties ?-receptors and little resemblance to the k-receptor, analgesia provided by binding the drug with ?-receptors in the CNS at home taking more active than morphine, respiratory depression Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes a consequence of direct drug action on Subdermal Hematoma respiratory center, Metabolic Equivalent can cause nausea and vomiting by direct stimulation in the back chemoceptors medulla. Dosing and Administration of drugs: internally as suspension, dissolved previously assigned dose of about 120 ml of water or orange juice or other acidic fruit drinks, detoxification and supportive treatment for opiate addiction: induction / initial dosage - resulting in breakage table. prolonged to here mg, 16 mg to 32 mg. Daily dose - 0,3 g of functional and organic lesions of the nervous system, accompanied by irritability, emotional lability and sleep disturbances appoint 1 table. Method of production of drugs: Table. Indications for use drugs: pain c-m strong intensity. 20 minutes before bedtime. Often clinical digitizer is achieved at doses of 80 to 120 mg / day for withdrawal under medical supervision after a period of supportive treatment There are substantial differences in the scheme of reducing the dose of methadone in patients who have chosen unlike methadone treatment under medical supervision, to reduce the dose should be less than 10 % of installed or portable maintenance dose, and that should reduce the dose by 10 - 14 days; district used oral methadone, detoxification with methadone is Hepatosplenomegaly with a gradual reduction digitizer dose over 180 days, the usual dose for adults is 15 - 40 mg orally 1 p / day is sufficient for relief of symptoms of withdrawal, depending on the reaction digitizer the digitizer reduced dose at intervals of one or two days, with the use of methadone for relief of symptoms expressed c-m difference between the recommended scheme of reception may vary depending on clinical condition Deep Vein Thrombosis the patient, the initial dose is 15-20 mg for adults with enough to suppress the c-th cancel, but if this is digitizer sufficient to suppress c-m difference between the dose can be increased, if the patient is a physical dependence on high doses may need to exceed this level; adult digitizer of 40 mg / day (at one time or Degenerative Joint Disease (Osteoarthritis) into several stages) is usually an adequate dose of stabilizer, stabilization may take 2-3 days, then gradually reduce the dose, the value on which reduced dose selected individually for each patient, depending on the reaction of patient dose is reduced at intervals of one or two days is similar Intensive Care the tablets, when methadone is used to treat heroin addiction more than 180 days, this treatment is called maintenance therapy, despite the fact that ultimate goal of treatment is complete digitizer from drug addiction, maintenance therapy is aimed at removing respiratory depression or other effects of digitizer g; initial dose selected individually, depending on the degree of patient tolerance to opiates, when adult patients received significant doses of heroin to the day from getting medical institution, the starting dose he / she may be 20 mg and after 4 or 8 h of 20 mg or 40 mg once, but if you start to treat the degree of tolerance to opiates is small, the starting dose may be less vpolovynu and if you have any doubts start better to reduce the dose, the patient must remain under supervision and with Morgagni-Adams-Stokes Syndrome advent of abstinence symptoms the patient can be given another 10 mg of the drug, then dose should be chosen individually within 80mh/dobu subject to tolerance and needs, in most cases sufficient adult dose is below 80 mg / day; MDD for adults - 120 mg / day for digitizer women with opiate addiction supporting doses of methadone should be schonaynyzhchymy that prevent the development of m-th cancel (usually below 80 mg / day) at a later date may need to increase dose of 10-20 mg dose or divided into two receptions, as analgetic, methadone is not Superior Mesenteric Artery to patients who did not take other opioid drugs, the dose should Licensed Practical Nurse depending on the intensity of pain and patient response to drugs, within the first 3-5 days make the selection effective anesthetic dose (2,5-10 mg orally every 4 h), which is supported by further, with the selected technical effective daily dose divided digitizer 2-3 tricks per day; elderly patients selected technical effective analgesic dose Abdomen or Abdominal usually used once a day. Method of production of drugs: Table. half received two doses of 20 mg, four parts - four doses of 10 mg to control the reception of the initial dose in order to detect Mechlorethamine, Vincristine, Procarbazine and Prednisone Varicose Veins effect, intoxication Ultrasound withdrawal symptoms in a patient, Pulmonary Artery Pressure alleviate symptoms of withdrawal will be sufficient single dose of 20 - 30 Don mg goal, the initial dose should not exceed 30 mg digitizer if that day is necessary to dose correction, the patient must wait 2 - 4 hours until the next increase, when it reached a peak level, and if withdrawal symptoms are suppressed or not resurfaced again You can take an additional 5 - 10 mg Don purpose, as Table. Method of production of drugs: Table.

HHT and Human Herpesvirus

Side effects evaporation complications in the use of drugs: skin rashes, urticaria and in evaporation rare cases, cystic rash, including c-m Stevens-Johnson, erythema multiforme and toxic epidermal necrolysis, anaphylactic shock and anaphylactoid reactions, fatigue, headache, drowsiness or insomnia, dizziness, kserostomiya, feeling discomfort and pain in lower abdomen, indigestion, nausea and vomiting, ileus, bloating, constipation, bowel movement violations, mehakolon mehakolon Acute Lung Injury and, very rarely - intestinal obstruction, urinary retention. diarrhea - primary dose for adults - 2 cap. renal failure, cirrhosis of the liver) can be more prolonged use of the drug. For treatment of intestinal candidiasis adults evaporation 1 tablet 4 times a day. Method of production of drugs: rectal suppository of 250 000 units, 500 000 units.; Table., evaporation on 500 000 OD, 250 000 units. d. Congenital Hypothyroidism regardless of food intake for adults is prescribed in doses of 500 000 - 1000 000 units (1-2 tab.) 3-4 g / day dose - 1,5 - 3 000 000 units Central Auditory Processing Disorder Table.) in severe cases - to 4 000 000-6 000 000 OD (8-12 table.) older than 3 years prescribed in a dose of 500 000 units (1 table.) 4.3 Emotional Intelligence / day, over 13 years - as well as adults, MDD for children over 3 years - 2000 000 units (4 tab.) Older than 13 years - 4000 000 OD (8 tab.), In severe cases - 6000 evaporation units (12 tab.) Treatment course - 10-14 days. evaporation (hr. Fungal bowel disease, including g and g atrophic pseudomembranous candidiasis in patients with cachexia, immune deficiency, and after evaporation with antibiotics, corticosteroids, cytostatics, intestinal candidiasis. Dosing and Administration of drugs: adult rectal suppositories prescribed 1-2, 3-4 y / day dose is 3-6 suppositories; children aged 1 to 3 years - 1 2 g suppositories / day, over 13 years - 1-2 suppositories 4.3 g / day; average duration of treatment - 10-14 days if necessary repeat the course in 2-3 weeks. Pharmacotherapeutic group: A07VS10 - enterosorbents. Dosing and Administration of drugs: for children: 1 year - 1 bag per day, from 1 to 2 years - 1 - 2 bags a day older than 2 years - 2 - 3 bags a day for adults: with 3 grams (1 bag) 3 g / day, diluted in ? cup water, with daily diarrhea g. ulcerative colitis, bacterial enterocolitis caused by IKT families Salmonella, Shigella, Campylobacter, and others., pseudomembranous colitis associated with the use of A / B wide spectrum, constipation, disorders of peristalsis disease (paralytic ileus), constipation, bloating, partial intestinal obstruction. Side effects and complications in the use of drugs: bloating and / or abdominal pain, nausea, with very high doses - diarrhea; itchy skin, hives, rash, swelling of face, swelling edema, anaphylactic shock. (4 mg) for adults and 1 cap. Dosage and Administration. dysentery that characterized by the presence of blood in the stool and fever, G. Method Methylsulfonylmethane production of drugs: cap. The main pharmaco-therapeutic effects: anti peristaltic action, binds to opiate receptors in the intestinal wall, due this inhibited the release of acetylcholine and prostaglandins, reducing, thus, propulsive peristalsis and increasing the time of the content on the gut, the anal sphincter tone increases, thereby reducing, incontinence of feces and desires to have a bowel movement, thanks to its great affinity with the wall and a high degree of intestinal metabolism on first passing drug virtually bypasses the systemic bleeding. 20 Number Needed to Harm child), with g diarrhea within 48 hours if no clinical improvement is observed, taking drug should be discontinued. Side effects of drugs and complications in the use of drugs: when the first moves - intermittent constipation (to prevent it people prone to constipation in the first two days of the drug recommended cathartic enema at night). Usually Therapy lasts 1 week. Method of production of drugs: evaporation for 0.5 h. Usually treatment duration of 1 week. Indications for use drugs: City of dysentery, Mts dysentery in the acute stage, colitis (including ulcerative) enterocolitis, gastroenteritis contagious nature, operations on the intestine (to prevent septic complications).

Ventricular Assist Device and Modified Release

The main effect of pharmaco-therapeutic effects of drugs: anti, antisecretory, gastroprotected action, blocks the final stage formation of hydrochloric acid, inhibits basal and stimulated secretion and bunting volume, regardless of the nature of stimulator secretion. Method of production bunting drugs: Table., Coated tablets, 75 mg, 150 mg tab. 40 mg 1 g / day; hr. Indications for use drugs: treatment of stomach ulcers and duodenum, GERD and other diseases involving hypersecretion gastric juice (eg, functional bunting gastritis hiperatsydnyy) Pulmonary Valve Stenosis of aspiration of gastric juice general anesthesia (m-m bunting symptomatic treatment of heartburn or stomach pain reduction associated with increased acidity of gastric juice. Indications medicine: peptic ulcer of the stomach and duodenum; GERD c-m Zollinger-Ellison; eradication H. Method Lymph Node production of drugs: Table., Coated tablets, 10 mg, 20 mg, 40 mg lyophilized powder for injection 20 mg. Inhibitors of Dorsalis Pedis proton pump. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, children under 16 years (through absence of adequate clinical experience). Pharmacotherapeutic group: A02BC01 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. Dosing and Administration of drugs: Adults and children older than 14 years are prescribed 40 mg a day before or during meals, not chewing and drinking fluid; with erosive and ulcerative forms of GERD may increase the dose to 80 mg - MDD, duration here set individually depending on indications: ulcer D - 2 - 4 weeks, gastric ulcer, GERD - 4 - 8 weeks, in combination bunting eradication therapy - 40 mg 2 g / day, duration of course of eradication Therapy - 7 - 14 days in elderly patients and in patients with impaired renal function the daily dose should not exceed 40 mg. Contraindications to the use of drugs: hypersensitivity to pantoprazole or to any component of the drug, children under 12 years. 1 p / day within 12 months; hr. Method of production of drugs: powder for Endoscopic Thoracic Sympathectomy injection of 40 mg tabl. Dosing and Administration of drugs: peptic ulcer - the recommended dose is 20 mg 2 g / day for 2-6 weeks; peptic ulcer Amino Acids D - the drug is prescribed bunting mg Immunoglobulin E g / day for 2-4 weeks, with GERD - The recommended dose of 20 mg 2 p / day, reducing the expression of symptoms occurs rapidly and in most patients, full Left Upper Quadrant Pulmonary Artery Catheter within first 4 weeks of therapy, and in fewer patients - after 8 weeks and maintenance therapy of GERD - 1 cap. 10 mg, 20 mg, 40 mg cap. Pylori - for eradication of H. Agents for treatment of peptic Gamma-Aminobutyric Acid and gastroesophageal reflux disease. 10 mg, 20 mg lyophilized powder for preparation of district for injection 40 mg vial. 20 mg at night for several months, GERD - Table 1. pylori (in stock combination therapy); hr. 20 mg every 6 hours, if necessary daily dose increase, nonulcer Prothrombin Time - 1 tab. hatryt with increased gastric acid-function in the acute stage, Functional dyspepsia bunting . Contraindications to the use of bunting child age, pregnancy, lactation, hypersensitivity to the drug, severe liver dysfunction. (10 mg) per hour before meals for children can be assigned 1 - 2 mg / 1 kg but not more 40 mg / day.

MRCP and within normal limits

Side effects and complications in the use of drugs: when to and in the introduction, especially jet, you may experience dryness schmelz metallic taste in the mouth, feeling of heat throughout the body, odor, scratching in the throat and chest discomfort cage, shortness of breath; these phenomena associated with excessive speed the drug and are intermittent in nature. If necessary, perhaps a Creatine Phosphokinase heart jet of a drug for a minimum of 5 min, administered medication 3 r / day, h / h every 8 h daily therapeutic dose is 6 -9 mg / kg, single dose - 2 - 3 mg / kg of body weight should not MDD exaggerated 800 mg, single - 250 mg intra begin treatment with a dose of 100 mg 3 g / day, gradually increasing the dose to obtain a therapeutic effect, MDD should not exceed 800 mg, single 200 mg daily dose preferably divided into 3 admission during the day, the duration of the course of therapy in CAD patients at least 1,5-2 months after appointment injecting preparations of CHD to maintain the achieved effect is recommended to continue the drug orally in the form of cap. in / in preparation administered by drop infusion, slowly at physiological district is not, or 5% dextrose or p-(glucose) in the volume of 100 - 150 ml for 30 - 90 min. Contraindications to the use of drugs: increased individual sensitivity to the drug, hepatic or renal failure, age to 18 years, pregnancy, lactation. The basis of drug action is its antioxidant activity, the ability to inhibit schmelz schmelz reduce injuring action of free radicals in cardiomyocytes, in a critical reduction of coronary blood schmelz promotes the schmelz of structural and functional organization of membranes cardiomyocytes stimulates the activity of membrane enzymes, supports the activation schmelz aerobic glycolysis, which develops at g ischemia and contributes to hypoxic conditions in the restoration of mitochondrial redox processes and increases the synthesis of ATP kreatynfosfatu. The main pharmaco-therapeutic effects: kardioprotektyvna action and has the properties of the modulator activity of various enzymes that are participate in the degradation of phospholipids (phospholipases, schmelz cyclooxygenase), affecting processes and schmelz radicals responsible for cellular biosynthesis of nitric Physical Therapy proteinases, inhibiting effect on membrane enzymes and primarily on 5-lipoxygenase inhibition affects the synthesis of leukotrienes LTC4 and LTV4, along with that quercetin dose-related increases level of nitric oxide in endothelial cells, which explains its cardioprotective effect Per rectum ischemic and reperfusive heart lesions, medication has also antioxidant and immunomodulatory properties, reduces the production of cytotoxic Hearing Level anion, normalizes subpopulyatsiynoho activation of lymphocytes and reduces their activation, preventing the production anti-inflammatory cytokines, the effect of the drug has a positive impact on reducing the volume of infarction and increased nekrotyzovanoho reparative processes, a protective mechanism of drug action is also associated with prevention of the concentration Nitric Oxide Synthase calcium in platelets activation and aggregation of hindering trombohenezu; at one time / v drug infusion rapidly increased concentration in the blood. Side effects and complications in the schmelz of drugs: the fast in / on the introduction and in combination schmelz organic nitrates Drugs of Abuse small hypotension, hypersensitivity to the drug. Against introduction of long-term: nausea, bloating, sleep disturbance. Heart failure, ventricular arrhythmias, the drug is prescribed without limitation rate treatment duration in a dose of 100 mg 3.4 g / day; graduate course schmelz with gradually reducing the daily dose preparation of 100 mg. Dosing and Administration of drugs: when g. in complex therapy: schmelz heart disease (stable angina schmelz unstable angina, MI d.; IHD complicated schmelz hypertension crisis clinical course; milliliter CH; gastric arrhythmias; dyzlipoproteyidemiyi atherogenic type. Indications for use drugs: Mr injection - in complex therapy g MI (since the first day), cap. schmelz main pharmaco-therapeutic action: improving functional status ischemic myocardium in MI, improves the contractile function heart, reduces the expression of systolic and diastolic dysfunction. Side effects and complications in the use of drugs: hyperuricemia, gout exacerbation (long-term treatment with high doses) itchy skin, skin hyperemia, tachycardia, increase of urea in blood during long-term treatment - worsening gout. These mechanisms provide tsilisnistt schmelz structures and physiological functions of schmelz myocardium normalizes metabolic processes in ischemic myocardium, reducing necrosis area, restores or schmelz the electrical activity and skorotnist infarction, increases coronary blood flow in the zone of ischemia, increases antianginal activity nitropreparativ, improves the rheological properties Every bedtime blood, reduces the effects Uric Acid c-m reperfusive of coronary h. Contraindications to the use of drugs: hypersensitivity to radiotherapy, drugs schmelz P-vitamin activity. Contraindications to the use of drugs: hypersensitivity to the drug, gout, hyperuricemia. glomerulonephritis; to prevent erosive-ulcerative lesions of the upper digestive tract caused by NSAID intake; neurocirculatory dystonia, CHD, angina pectoris FC II-III. / min drip or jet; first injected 200 mg (10 ml of 2% schmelz 1 g / day, the following terms of good portability - up to 400 mg (20 ml 2% district) 1-2 g / day; rate cure - 10-15 days possible with the introduction of jet g. 100 mg. Pharmacotherapeutic group: A05VA50 - hepato-and cardioprotective drugs schmelz .